logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onCalendarPlatformsJob offersTools
 

Breast cancer

imatge Central Grup Recerca

Scientific Team

Researchers
Miguel Angel Pujana
Postdoctoral researchers
Helena Aguilar
Collaborators
Fernando Moreno, Sonia Pernas
Predoctoral researchers
Nuria Bonifaci, Griselda Martrat, Jordi Serra-Musach
Technicians
Susana Lopez

Research lines

Predictive models of breast cancer risk associted to BRCA 1 & 2 and their modifiers

 

 

FA/BRCA pathway and its rol in breast cancer risk

 

Pre-clinical developement of novel therapies in endocrine resistant breast cancer


Gene expression and phenotipic characterization of ductal carcinoma in situ of the breast towards the delineation of invasion risk


Selected papers (2012)

 

Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, Sargent RL, Espinet B, Climent F, Jacobs SA, Delabie J, Naresh KN, Bagg A, Brousset P, Warnke RA, Serrano S, Harris NL, Swerdlow SH, Jaffe ES, Campo E. Carvajal- Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, Sargent RL, Espinet B, Climent F, Jacobs SA, Delabie J, Naresh KN, Bagg A, Brousset P, Warnke RA, Serrano S, Harris NL, Swerdlow SH, Jaffe ES, Campo E.
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2012 Feb;97(2):270-8

 

Serra-Musach J, Aguilar H, Iorio F, Comellas F, Berenguer A, Brunet J, Saez-Rodriguez J, Pujana MA..
Cancer develops, progresses and responds to therapies through restricted perturbation of the protein-protein interaction network
INTEGRATIVE BIOLOGY2012 Sep;4(9):1038-48

 

APernas S, Gil-Gil M, de Olza MO, Gumà A, Climent F, Petit A, Pla MJ, García-Tejedor A, López-Ojeda A, Falo C, Fernandez-Otega A, Mesia C, Pérez-Martin FJ, Urruticoechea A, Germà JR.
Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel- FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice
BREAST CANCER RESEARCH AND TREATMENT 2012 Aug;134(3):1161-8

 

Fernández-Rodríguez J, Quiles F, Blanco I, Teulé A, Feliubadaló L, Valle JD, Salinas M, Izquierdo A, Darder E, Schindler D, Capellá G, Brunet J, Lázaro C, Pujana MA.
Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families
BMC CANCER 2012 Mar 8;12:84

imatge personal
 

Group leader

Miguel Angel Pujana
Telephone  
+34 932607463
E-mail  
mgenestar@idibell.cat
 
© 2014 Institut d'Investigació Biomèdica de Bellvitge



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




You have not yet answered the internal personal satisfaction survey. It will not take you more than five minutes. Your opinion is very important to improve IDIBELL.

Do you want to complete the survey now?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No